Health Insights UK

Industry-leading Polygenic Risk Scores

Health Insights is a genetic test developed by Genomics that predicts an individual's risk of common diseases using Polygenic Risk Scores (PRS). We analyse millions of genetic variants and combine their effects into a PRS, which we integrate with age, sex at birth, and ethnicity to deliver a personalised risk estimate for common health conditions.

The predictive power of our PRS consistently outperforms others and sets the industry benchmark for accuracy.

Learn more

Available nationwide with leading healthcare providers

GSK logo
Novo Nordisk logo

Conditions covered

Heart attacks & strokes

Our integrated risk tool for cardiovascular disease (CVD) combines polygenic risk with demographic factors and the QRISK3 clinical risk calculator. In the HEART trial, 24% of participants had a clinically significant change in risk after PRS was added.

Type 2 diabetes

Our integrated risk tool for Type 2 diabetes combines polygenic risk with demographic factors and the QDiabetes clinical risk calculator. The IRT detects elevated genetic risk well before clinical markers change, enabling early lifestyle or pharmacological intervention.

Breast cancer

Our PRS identifies high-risk individuals even in the absence of family history, outperforming traditional risk models.

Prostate cancer

Our PRS identifies high-risk individuals even in the absence of family history, outperforming traditional risk models.

Healthcare worker and elderly patient smiling while reviewing health information on a mobile phone, representing Genomics’ contribution to risk detection in community care settings.
A simple workflow designed for clinic and patient convenience

Our end-to-end solution

Health Insights provides a comprehensive testing service designed to minimise disruption to clinical workflows. Genomics handles the core testing process, so you can focus on high quality care delivery.

  • To initiate the process, your clinic conducts a routine health assessment including blood draws for HbA1c and lipids and registers the patient on the Genomics provider portal.
  • After registration, Genomics manages all subsequent testing processes, including sample collection, processing and analysis. Once this is complete, we securely transfer the final report to your clinic.
  • Your clinic conducts a brief follow up consultation (~20 minutes) to guide patients through their personalised report and discuss appropriate care pathways, with support fromGenomics training resources.
Delivering real impact for patients and clinics

A win-win for patients and clinics

Support better health outcomes by helping patients take proactive steps towards prevention through personalised risk insights, empowering earlier interventions and improving overall health.

Clinics can drive re-engagement through the identification of high-risk individuals and support patients in securing necessary follow-up screenings and tests; all whilst reinforcing a clinic’s brand of being at the forefront of personalised care and cutting-edge services.

Clinician consulting with a patient in a medical exam room, highlighting Genomics’ efforts to identify high-risk individuals early through genetic testing.
Nurse in blue scrubs working at a computer in a clinical setting, symbolizing the integration of Genomics’ digital tools and polygenic insights into NHS systems.
Precision That Makes a Difference

Trust, privacy and compliance

  • We will never sell personal information or genetic data and patients may ask us to stop using their data at any time.
  • Our privacy and security processes have been designed to meet applicable HIPAA and UK GDPR requirements
  • Partnered with ISO 15189 certified laboratories
  • UKCA marked device

Frequently Asked Questions

How is this test different from others?
Our genetic test looks at millions of common variants in your DNA to predict your risk of developing common health conditions. This is different from genetic testing that looks at specific rare variants linked to rare health conditions.

It is also different from ancestry testing that looks at a person’s DNA for clues about where their ancestors might have come from.
Who is the test for?
Adults seeking to understand personal risk for the included conditions.
Is this diagnostic?
No. It provides risk information to guide prevention and screening.
What conditions are included?
CVD, type 2 diabetes, breast cancer (female participants), prostate cancer (male participants).
How are results delivered?
In a clinical consultation, with a patient summary.
What about family history?
PRS captures genetic risk beyond family history and can be informative regardless of it.

Earlier prevention starts with better risk information

Enquire for your organisation